Results 141 to 150 of about 1,214,788 (299)
Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer
Molecular Oncology, EarlyView.Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola +11 more
wiley +1 more source
Why Are Scholarly Journals Costly even with Electronic Publishing? [PDF]
, 2009 Journal literature has long played a prominent role in the scholarly communication chain. In recent decades, however, the scholarly communication system has been facing a crisis due to the ever-escalating costs of journals.
Galyani-Moghaddam, Golnessa
core
The “International Network for the Advancement of Medicine, Psychology, and Public Health”: Pioneering progress in medicine and social development [PDF]
Advances in Medicine, Psychology, and Public HealthFrancesco Chirico
doaj +1 more source
Molecular Oncology, EarlyView.Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller +10 more
wiley +1 more source
Publishing an E-journal on a shoe string: Is it a sustainaible project?. [PDF]
The aim of this article is to report on an experiment in publishing an open access journal and learn from it about the larger field of open access publishing.
Valli, Vittorio +3 more
core
Publishing scientific research [PDF]
, 2012 Springer Author workshop for postgraduate students and researchers, presented on Tuesday, 28 February 2012, in the Library auditorium, Level 3, Merensky Library II, University of Pretoria,Springer Author workshop for postgraduate students and researchers
Flipsen, Jacco
core
Molecular Oncology, EarlyView.Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq +8 more
wiley +1 more source
Molecular Oncology, EarlyView.BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi +11 more
wiley +1 more source
The ethics of scientific publishing [PDF]
Dentomaxillofacial Radiology, 2012 openaire +2 more sources